<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14740</article-id><article-id pub-id-type="doi">10.7554/eLife.14740</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-52050"><name><surname>Hengel</surname><given-names>Sarah R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52051"><name><surname>Malacaria</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52055"><name><surname>Folly da Silva Constantino</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52052"><name><surname>Bain</surname><given-names>Fletcher E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52053"><name><surname>Diaz</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52054"><name><surname>Koch</surname><given-names>Brandon G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16448"><name><surname>Yu</surname><given-names>Liping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52057"><name><surname>Wu</surname><given-names>Meng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52067"><name><surname>Pichierri</surname><given-names>Pietro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-52058"><name><surname>Spies</surname><given-names>Michael Ashley</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2994"><name><surname>Spies</surname><given-names>Maria</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7375-8037</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Iowa</institution>, <addr-line><named-content content-type="city">Iowa City</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Environment and Health</institution>, <institution>Istituto Superiore di Sanita</institution>, <addr-line><named-content content-type="city">Rome</named-content></addr-line>, <country>Italy</country></aff><aff id="aff3"><institution content-type="dept">Department of Pharmaceutical Sciences and Experimental Therapeutics</institution>, <institution>University of Iowa</institution>, <addr-line><named-content content-type="city">Iowa City</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1520"><name><surname>Ha</surname><given-names>Taekjip</given-names></name><role>Reviewing editor</role><aff><institution>Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>m-ashley-spies@uiowa.edu</email> (MS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>maria.g.spies@gmail.com</email> (MS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>07</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e14740</elocation-id><supplementary-material><ext-link xlink:href="elife-14740-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>01</day><month>02</month><year>2016</year></date><date date-type="accepted"><day>18</day><month>07</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Hengel et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Hengel et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The DNA repair protein RAD52 is an emerging therapeutic target of high importance for BRCA-deficient tumors. Depletion of RAD52 is synthetically lethal with defects in tumor suppressors <italic>BRCA1</italic>, <italic>BRCA2</italic> and <italic>PALB2</italic>. RAD52 also participates in recovery of the stalled replication forks. Anticipating that ssDNA binding activity underlies the RAD52 cellular functions, we carried out a high throughput screening campaign to identify compounds that disrupt the RAD52-ssDNA interaction. Lead compounds were confirmed as RAD52 inhibitors in biochemical assays. Computational analysis predicted that these inhibitors bind within the ssDNA-binding groove of the RAD52 oligomeric ring. The nature of the inhibtor-RAD52 complex was validated through an <italic>in silico</italic> screening campaign, culminating in the discovery of an additional RAD52 inhibitor. Cellular studies with our inhibitors showed that the RAD52-ssDNA interaction enables its function at stalled replication forks, and that the inhibition of RAD52-ssDNA binding acts additively with BRCA2 or MUS81 depletion in cell killing.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>RSG-09-182-01-DMC</award-id><principal-award-recipient><name><surname>Spies</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH R01-GM097373</award-id><principal-award-recipient><name><surname>Spies</surname><given-names>Michael Ashley</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1S10RR029274-01</award-id><principal-award-recipient><name><surname>Wu</surname><given-names>Meng</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Itallian Association of Cancer Research</institution></institution-wrap></funding-source><award-id>AIRC, IG13398</award-id><principal-award-recipient><name><surname>Pichierri</surname><given-names>Pietro</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Nando-Peretti Foundation</institution></institution-wrap></funding-source><award-id>2012-113</award-id><principal-award-recipient><name><surname>Pichierri</surname><given-names>Pietro</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>CAPES</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Folly da Silva Constantino</surname><given-names>Laura</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec></back></article>